期刊文献+

肺癌骨转移特征临床分析 被引量:9

Analysis of Early Symptoms on clinical features of lung cancer with osseous metastases.
下载PDF
导出
摘要 目的探讨肺癌早期骨转移的临床特点。方法临床资料回顾性分析。结果早期肺癌骨转移病人临床主要表现为不同程度的疼痛,亦可无临床症状。60例肺癌骨转移患者中腺癌58.3%,鳞癌26.7%,小细胞肺癌11.7%,混合癌3.3%。骨转移部位有胸部70.0%,脊柱65%,骨盆53.3%,四肢45%,头颅38.3%。结论肺癌骨转移以多发性、溶骨性骨破坏为特征。腺癌骨转移发生率最高,其次为鳞癌及小细胞癌。通过X线平片、电子计算机断层扫描(CT)、磁共振(MRI)、放射性核素显像(ECT)检查能协助早期肺癌骨转移癌的诊断。 Objective To research the clinical features of lung cancer with osseous metastases. Methods The clinical materials were retrospectively analysed.Results In all the 60 cascs,58.3% was adenoearcinoma,26.7% squamous carcinoma, 11.7% sinail cell lung cancer,3.3 % mixed carcinoma. The frequencies of metastasis sites were as follows, eg, ribs ( 70.0% ), thoracic and lumber verte- brae (65.0%), pelvis (53.3% ) ,limbs (45.0%).Conclusion Osseous metastasis in patients with lung cancer is characterized by multiple osteolytic damages.Adenocarcinoma is one of the most common types of lung cancer that causes osseous metastasis.X-ray, CT, and ECT bone scan were effective methods for early diagnosis and early treatment can improve quality of live and lengthen the survival time.
出处 《四川医学》 CAS 2006年第4期382-383,共2页 Sichuan Medical Journal
关键词 肺癌 骨转移 早期症状 诊断 骨扫描 lung cancer osseous metastasis diagnosis early symptoms bone scan
  • 相关文献

参考文献8

二级参考文献10

  • 1de la Piedra C, Castro-Errecaborde NA, Traba ML, et al.Bone remodeling markers in the detection of bone metastases in prostate cancer. Clin Chim Acta, 2003;331(1-2):45.
  • 2Alexandrakis MG, Passam FH, Malliaraki N, et al. Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patients. Clin Chim Acta,2002;325(1-2):51.
  • 3Costa L, Demers LM, Gouveia-Oliveira A,et al. Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status. J Clin Oncol, 2002;20(3):850.
  • 4Fink B, Feldkamp J, Fox F, et al. Time course of osteocalcin, bone-specific alkaline phosphatase, and C-terminal procollagen peptide during callus distraction. J Pediatr Orthop,2001;21(2):246.
  • 5Delmas PD, Hardy P, Garnero P, et al. Monitoring individual response to hormone replacement therapy with bone markers. Bone,2000;26(6):553.
  • 6Alvarez L, RicOs C, Peris P, et al. Components of biological variation of biochemical markers of bone turnover in Paget's bone disease. Bone,2000;26(6):571.
  • 7Fohr B, Dunstan CR, Seibel MJ. Clinical review 165: Markers of bone remodeling in metastatic bone disease. J Clin Endocrinol Metab,2003;88(11):5059.
  • 8Takahashi M, Kushida K, Nagano A, et al. Comparison of the analytical and clinical performance characteristics of an N-MID versus an intact osteocalcin immunoradiometric assay. Clin Chim Acta,2000;294(1-2):67.
  • 9Demers LM, Costa L, Lipton A. Biochemical markers and skelet al metastases. Clinical Orthopaedics & Related Research,2003;(415 Suppl):S138.
  • 10唐志毅,肖路延,罗玲.一种新的高效液相色谱法选择性测定尿羟脯氨酸[J].中华医学检验杂志,1999,22(4):210-212. 被引量:21

共引文献13

同被引文献57

引证文献9

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部